Standard BioTools Inc. (BX:FLB) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Eli Casdin Other companies: GeneDx Holdings Corp. (Board Member · Since at least Apr 27, 2022); 2Seventy Bio Inc (Director · Mar 20, 2024 – May 13, 2025 · Past); EQRx Inc (Director · Sep 30, 2022 – Sep 30, 2022 · Past); Tenaya Therapeutics, Inc. (Director · Jun 10, 2022 – Nov 17, 2022 · Past); Century Therapeutics, Inc. (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Absci Corporation (Director · Jun 8, 2022 – Jun 8, 2022 · Past) | Director · Since at least Apr 4, 2022 |
| Carlos Paya Other companies: Collegium Pharmaceutical, Inc. (Director · Since at least May 15, 2025); Vaxcyte, Inc. (President, Immune Design Corp Chairman, Vaxcyte · Since at least Oct 27, 2021); Mallinckrodt Inc (Director · May 22, 2019 – Jun 16, 2022 · Past); Immune Design Corp (President and CEO, Director · Oct 30, 2015 – Apr 2, 2019 · Past) | Director · Mar 23, 2017 – Jun 14, 2023 · Past |
| Evan Jones Other companies: Veracyte, Inc. (Board Member · Since at least Oct 29, 2013); CapForce Inc. (Director · May 4, 2015 – May 17, 2021 · Past); Foundation Medicine Inc (Director · Sep 24, 2013 – Jul 31, 2018 · Past); CAS Medical Systems Inc (Director · Jun 20, 2012 – Jun 24, 2013 · Past) | Director · Dec 12, 2011 – Jul 31, 2017 · Past |
| Frank R. Witney Other companies: Alamar Biosciences, Inc. (Director · Since at least Apr 16, 2026); Cerus Corporation (Director · Since at least May 9, 2024); Revvity, Inc. (Director · Since at least May 1, 2024); Telesis Bio, Inc. (Director · Jul 6, 2023 – Jul 6, 2023 · Past) | Director · Since at least Jun 28, 2024 |
| Laura Clague Other companies: Travere Therapeutics, Inc. (Chief Financial Officer · Nov 17, 2014 – May 10, 2022 · Past); Turtle Beach Corporation (Director · Aug 23, 2010 – Aug 23, 2010 · Past); Genasys Inc. (Director · Dec 8, 2008 – Apr 27, 2022 · Past) | Director · Oct 30, 2018 – Jun 14, 2023 · Past |
| Nicolas M. Barthelemy Other companies: Repligen Corporation (Director · Since at least May 11, 2016); 908 Devices Inc. (Director · Dec 17, 2020 – Jun 15, 2022 · Past); Twist Bioscience Corporation (Director · Oct 24, 2019 – Nov 21, 2022 · Past) | Director · Mar 23, 2017 – Apr 1, 2022 · Past |
| Troy Cox Other companies: MapLight Therapeutics, Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least Jun 23, 2026); Sophia Genetics SA (Board Member and Lead Independent Director · Since at least Jun 10, 2026) | Director · Since at least Jun 18, 2026 |
| Jeffrey G Black Other companies: Exagen Inc. (Chief Financial Officer · Since at least Sep 1, 2024) | SVP & Chief Financial Officer · May 15, 2024 – Aug 20, 2024 · Past |
| Jennifer Ling Lee Other companies: Moderna, Inc. (Chief Accounting Officer · Dec 7, 2018 – Mar 9, 2020 · Past) | See Remarks · May 18, 2016 – Feb 20, 2018 · Past |
| Thomas D Carey Other companies: EXACT Sciences Corporation (Director · Apr 29, 2013 – Jun 2, 2021 · Past) | Director · Since at least Jan 5, 2024 |
| Alex Kim | CFO · Since at least Nov 4, 2025 |
| Ana K Stankovic | Director · Dec 15, 2020 – May 25, 2021 · Past |
| Anders Davas | Senior Vice President, Global Operations · Since at least Nov 5, 2026 |
| Betsy Jensen | Chief Human Resources Officer · Since at least Nov 5, 2026 |
| Bill Colston | Director · Jun 15, 2022 – Jun 15, 2022 · Past |
| Colin McCracken | Chief Commercial Officer · Apr 30, 2019 – Feb 22, 2022 · Past |
| Gajus Vincent Worthington | CHIEF EXECUTIVE OFFICER, Director · May 20, 2016 – Aug 22, 2016 · Past |
| Hanjoon Alex Kim | Chief Financial Officer · Since at least Apr 4, 2022 |
| Jeremy Steven Davis | SVP Chief Commercial Officer · Apr 4, 2022 – Feb 21, 2023 · Past |
| Mai Chan Yow | See Remarks · Feb 17, 2012 – Feb 20, 2018 · Past |
| Michael Egholm | President & CEO, Director · Since at least Apr 4, 2025 |
| Mike Musgnug | CTO · Since at least Nov 4, 2026 |
| Robert C Jones | See Remarks · May 20, 2016 – Aug 22, 2016 · Past |
| Sean MacKay | SVP & Chief Business Officer · Since at least May 21, 2025 |
| Sean MacKey | COO · Since at least Nov 4, 2026 |
| Standard BioTools’ | Investor Relations department · Since at least Nov 3, 2026 |
| Vikram Jog | Chief Financial Officer · Sep 20, 2017 – Feb 21, 2023 · Past |
| William Maxwell Smith | EVP, Legal Affairs · Oct 10, 2011 – Jun 20, 2016 · Past |